{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:39:23Z","timestamp":1782823163588,"version":"3.54.5"},"reference-count":49,"publisher":"American Society for Microbiology","issue":"18","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T00:00:00Z","timestamp":1568505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P-25499-B13"],"award-info":[{"award-number":["P-25499-B13"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["I-2550-B13"],"award-info":[{"award-number":["I-2550-B13"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006012","name":"Christian Doppler Forschungsgesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2019,9,15]]},"abstract":"<jats:p>Systemic application aims to deliver oncolytic viruses to tumors as well as to metastatic lesions. However, we found that xenoantigens incorporated onto the viral surface from nonhuman production cell lines are recognized by natural antibodies in human serum and that the virus is thereby inactivated by complement lysis. Hence, to maximize the effective dose, careful selection of cell lines for virus production is crucial.<\/jats:p>","DOI":"10.1128\/jvi.00567-19","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T10:44:10Z","timestamp":1561545850000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum"],"prefix":"10.1128","volume":"93","author":[{"given":"Lisa","family":"Pipperger","sequence":"first","affiliation":[{"name":"Division of Virology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Koske","sequence":"additional","affiliation":[{"name":"Division of Virology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wild","sequence":"additional","affiliation":[{"name":"Division of Virology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"M\u00fcllauer","sequence":"additional","affiliation":[{"name":"Division of Virology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Krenn","sequence":"additional","affiliation":[{"name":"Division of Virology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Stoiber","sequence":"additional","affiliation":[{"name":"Division of Virology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Wollmann","sequence":"additional","affiliation":[{"name":"Division of Virology, Medical University of Innsbruck, Innsbruck, Austria"},{"name":"Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Kimpel","sequence":"additional","affiliation":[{"name":"Division of Virology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"von Laer","sequence":"additional","affiliation":[{"name":"Division of Virology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3826-5800","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"B\u00e1nki","sequence":"additional","affiliation":[{"name":"Division of Virology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00866"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines5010008"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/02648725.2018.1474320"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.5.2259"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.4049\/jimmunol.126.4.1562","article-title":"Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human","volume":"126","author":"Beebe DP","year":"1981","unstructured":"Beebe DP, Cooper NR. 1981. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human. J Immunol 126:1562\u20131568.","journal-title":"J Immunol"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00074-14"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.12.045"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.3.1309-1327.2002"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02511-10"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-3306"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03276-13"},{"key":"e_1_3_2_13_2","first-page":"1251","article-title":"Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid","volume":"26","author":"Forsgren A","year":"1974","unstructured":"Forsgren A, Quie PG. 1974. Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid. Immunology 26:1251\u20131256.","journal-title":"Immunology"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.16.1.124-128.1977"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02177"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.162.2.573"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.2.2.125-131.1995"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)77900-9"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.2002.02138.x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajpa.10018"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00955-07"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2016.21"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.3390\/v10030108"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12829"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.10.4765-4775.2000"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2016.27"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1248943"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400844"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01154-12"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.03.060"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12110"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1291-1347"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.5.1345"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31823be870"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/v11020159"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(89)90088-4"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"4376 LP","DOI":"10.4049\/jimmunol.155.9.4376","article-title":"Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses: human T cell leukemia\/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV)","volume":"155","author":"Spear GT","year":"1995","unstructured":"Spear GT, Lurain NS, Parker CJ, Ghassemi M, Payne GH, Saifuddin M. 1995. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses: human T cell leukemia\/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J Immunol 155:4376 LP\u20134381.","journal-title":"J Immunol"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.1.307"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.2.912-921.2004"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2013.1"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302399"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2002.0547"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.49"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.12.015"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.6.4650-4656.1998"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045770"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00182319"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300155"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00666-08"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2003.09.008"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00567-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00567-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T19:39:29Z","timestamp":1694979569000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.00567-19"}},"subtitle":[],"editor":[{"given":"Susana","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,15]]},"references-count":49,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019,9,15]]}},"alternative-id":["10.1128\/JVI.00567-19"],"URL":"https:\/\/doi.org\/10.1128\/jvi.00567-19","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,15]]},"assertion":[{"value":"2019-04-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00567-19"}}